SPOP and breast carcinoma: Furthermore, we demonstrated that circLRBA could interact competitively with the E3 ubiquitin ligase SPOP to hinder the binding between SPOP and Twist1 and enhance the transcriptional activation of PD‐L1, thus promoting the EMT, chemoimmunotherapy resistance and metastasis of breast cancer (Figure11).